Why Preventing Cancer Is Not the Priority in Drug Development
- “There’s more money to be made investing in drugs that will extend cancer patients’ lives by a few months than in drugs that would prevent cancer in the first place.”
- “Developing drugs to treat late-stage disease is usually much faster than developing drugs to treat early-stage disease or prevention, because late-stage disease is aggressive and progresses rapidly. This allows companies to see results in clinical trials more quickly, even if those results are only small improvements in survival.”
- “Between 1973 and 2011, there were about 12,000 trials for relatively later-stage patients with a 90 percent chance of dying in five years.”
- “but only 500 for cancer prevention, which confer the longest survival gains”
Proof of prevention takes a long time
Generally the prevention drugs – including vitamin D – would provide little or no profit to big pharma
See also VitaminDWiki
- Molecular Link between Vitamin D and Cancer Prevention – Oct 2013
- Breast and other Cancer prevention - Dr. Wascher 2011 book
- Overview Cancer and vitamin D General Cancers and specifics - including Breast
- Vitamin D, Sunlight and Cancer Connection – Holick Jan 2013
- Vitamin D appears to both prevent and treat various cancers – Mar 2011
- Vitamin D and Cancer Treatment and Prevention – presentations May 2011
- Vitamin D and Prevention of Cancer — Is it ready for Prime Time – March 2011
- Curing patients is not a sustainable business model – Goldman Sachs – April 2018